CNR Institutional Research Information System

VIGLIETTO, GIUSEPPE

VIGLIETTO, GIUSEPPE  

Istituto degli Endotipi in Oncologia, Metabolismo e Immunologia "G. Salvatore" (IEOMI)  

Mostra records
Risultati 1 - 20 di 36 (tempo di esecuzione: 0.045 secondi).
Titolo Data di pubblicazione Autore(i) File
Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility. 1-gen-2011 Pierantoni GM; Esposito F; Tornincasa M; Rinaldo C; Viglietto G; Soddu S; Fusco A.
Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice 1-gen-2009 Fedele, M.; Palmieri, D.; Chiapetta, G.; Pasquinelli, R.; De Martino, I.; Arra, C.; Palma, G.; Valentino, T.; Pierantoni, G. M.; Viglietto, G.; Rothstein, J. L.; Santoro, M.; Fusco, A.
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. 1-gen-2006 Iervolino, A; Iuliano, R; Trapasso, F; Viglietto, G; Melillo, Rm; Carlomagno, F; Santoro, M; Fusco, A
A new mechanism of BRAF activation in human thyroid papillary carcinomas. 1-gen-2005 Fusco, A; Viglietto, G; Santoro, M
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. 1-gen-2005 Motti, Ml; Califano, D; Troncone, G; De Marco, C; Migliaccio, I; Palmieri, E; Pezzullo, L; Palombini, L; Fusco, A; Viglietto, G
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 1-gen-2005 Di Vizio, D; Cito, L; Boccia, A; Chieffi, P; Insabato, L; Pettinato, G; Motti, Ml; Schepis, F; D'Amico, W; Fabiani, F; Tavernise, B; Venuta, S; Fusco, A; Viglietto, G
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. 1-gen-2005 Fusco, A; Viglietto, G; Santoro, M
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. 1-gen-2005 Pera, Il; Iuliano, R; Florio, T; Susini, C; Trapasso, F; Santoro, M; Chiariotti, L; Schettini, G; Viglietto, G; Fusco, A
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 1-gen-2005 Fedele M; Pentimalli F; Baldassarre G; Battista S; KleinSzanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A.
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. 1-gen-2005 P Pallante; MT Berlingieri; G Troncone; M Kruhoffer; TF Orntoft; G Viglietto; A Caleo; I Migliaccio;M DecaussinPetrucci; M Santoro; L Palombini;A Fusco;
Akt-dependent T198 phosphorylation of cicli-dependent kinase inhibitor p27kip1 in breast cancer. 1-gen-2004 Motti, Ml; De Marco, C; Califano, D; Fusco, A; Viglietto, G
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. 1-gen-2004 Vitagliano D; Carlomagno F; Motti ML; Viglietto G; Nikiforov YE; Nikiforova MN;Hershman JM; Ryan AJ; Fusco A; Melillo RM; Santoro M.
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. 1-gen-2004 Trapasso, F; Sarti, M; Cesari, R; Yendamuri, S; Dumon, Kr; Aqeilan, Ri; Pentimalli, F; Infante, L; Alder, H; Abe, N; Watanabe, T; Viglietto, G; Croce, Cm; Fusco, A
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 1-gen-2003 Iuliano, R; Trapasso, F; Le Pera, I; Schepis, F; Sama, I; Clodomiro, A; Dumon, Kr; Santoro, M; Chiariotti, L; Viglietto, G; Fusco, A
Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland. 1-gen-2003 Motti, Ml; Boccia, A; Belletti, B; Bruni, P; Troncone, G; Cito, L; Monaco, M; Chiappetta, G; Baldassarre, G; Palombini, L; Fusco, A; Viglietto, G
DREAM is a transcriptional repressor involved in thyroid differentiation and function 1-gen-2003 Dandrea, B; Di Palma, T; Macchia, Pe; Terracciano, D; Motti, Ml; Viglietto, G; Mascia, A; Macchia, V; Di Lauro, R; Zannini, M
HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. 1-gen-2003 Masciullo V. ; Baldassarre G. ; Pentimalli F. ; Berlingieri M.T. ; Boccia A. ; Chiappetta G. ; Palazzo J. ; Manfioletti G. ; Giancotti V. ; Viglietto G. ; Scambia G. ; Fusco A.
Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples. 1-gen-2002 Curci, A; Capasso, I; Romano, A; Bruni, P; Motti, Ml; Pignata, S; D'Aiuto, G; Casamassimi, A; D'Urso, M; Fusco, A; Viglietto, G
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 1-gen-2002 Viglietto, G; Motti, Ml; Bruni, P; Melillo, Rm; D'Alessio, A; Califano, D; Vinci, F; Chiappetta, G; Tsichlis, P; Bellacosa, A; Fusco, A; Santoro, M
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). 1-gen-2002 Baldassarre G. ; Bruni P. ; Boccia A. ; Salvatore G. ; Melillo R.M. ; Motti M.L. ; Napolitano M. ; Belletti B. ; Fusco A. ; Santoro M. ; Viglietto G.